artenimol has been researched along with sybr green i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaratunga, C; Anderson, JM; Ashley, EA; Char, MC; Chy, S; Dek, D; Dondorp, AM; Eastman, RT; Fairhurst, RM; Lim, P; Mao, S; Menard, D; Miotto, O; Sam, B; Sopha, C; Sreng, S; Su, XZ; Suon, S; Try, V; White, NJ | 1 |
| Anderson, TJC; Button-Simons, KA; Cassady, Z; Checkley, LA; Davis, SZ; Ferdig, MT; Foster, GJ; McDew-White, M; Nosten, FH; Shoue, DA; Sievert, MAC; Singh, PP; Vendrely, KM | 1 |
2 other study(ies) available for artenimol and sybr green i
| Article | Year |
|---|---|
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
Topics: Antimalarials; Artemisinins; Benzothiazoles; Biomarkers; Cambodia; Diamines; DNA Copy Number Variations; Drug Combinations; Drug Resistance, Multiple; Epidemiological Monitoring; Gene Expression; Humans; Malaria, Falciparum; Microscopy, Fluorescence; Multidrug Resistance-Associated Proteins; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2013 |
The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput.
Topics: Antimalarials; Artemisinins; Benzothiazoles; Diamines; Drug Resistance; Erythrocytes; Flow Cytometry; Fluorescent Dyes; Half-Life; Humans; Malaria, Falciparum; Organic Chemicals; Parasitemia; Plasmodium falciparum; Povidone; Quinolines; Real-Time Polymerase Chain Reaction; Silicon Dioxide | 2020 |